NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Precedex Special Investigation (in Pediatric Patients)

CompletedN/A

Sponsor: Pfizer

Conditions: Sedation

Interventions: Dexmedetomidine Hydrochloride

Countries: Japan

Secondary Data Collection:To confirm the safety and effectiveness profiles under the actual medical practice of Precedex in Japan.

Eligibility overview

Sex: ALL

Age: 45 Weeks to 17 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Pediatric patients (45 weeks corrected gestational age to \<18 years old) administered this drug for "sedation during and after mechanical ventilation in the intensive care setting.

Exclusion Criteria:

* No exclusion criteria is set out in this study.

Locations (1)

Tokyo, Japan